[ad_1] The first trial would be with 50 critically ill Covid-19 patients to verify whether the intravenous drug Sepsivac, used against sepsis or blood poisoning, can reduce mortality. Track live updates on coronaviruses here The second trial would be with around 500 asymptomatic individuals, who may be close contacts of …
Read More »50-year-old bacterial drug returns in the fight against coronavirus
